Status:
COMPLETED
Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder
Lead Sponsor:
Denver Health and Hospital Authority
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The overarching goal of the study is to develop, pilot, and evaluate an intervention that aims to retain patients who initiate buprenorphine at Denver Health in ongoing treatment for opioid use disord...
Detailed Description
Initiating patients identified with opioid use disorder in hospital settings onto buprenorphine is a relatively new strategy to prevent overdose. While the literature is beginning to amass showing the...
Eligibility Criteria
Inclusion
- 18 years and older
- inducted onto buprenorphine at Denver Health
- successfully completed an intake visit at Denver Health's Outpatient Behavioral Health Services clinic.
Exclusion
- unable to provide informed consent
- unable to provide detailed contact information
- previously enrolled in the current study
- pregnant women will be excluded given that they are a priority treatment population and receive special services
Key Trial Info
Start Date :
March 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 29 2023
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04797962
Start Date
March 30 2021
End Date
September 29 2023
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health
Denver, Colorado, United States, 80203